Labviva Raises $8M in Seed Funding
- Labviva, a Cambridge, Mass.-based SaaS application for healthcare procurement, raised $8M in seed funding
- The round was led by Senator Investment Group, with participation from B Capital Group | Ascent and Glasswing Ventures
- The company intends to use the funds for further development of the platform with new product lines, including investment in operations and customer success platforms
- The company is an enterprise gateway marketplace (EGM) that integrates with major procurement solutions
- Organizations like pharmaceuticals and research institutions can coordinate their demand with the thousands of outside vendors who fulfill on the supply side
- In addition, the platform provides insight about the products and allows customers to have access to advanced analytics
